Breaking: Pharmaceutical Tariffs Announced
President Donald Trump has confirmed plans to impose tariffs on pharmaceutical imports, creating significant ripples throughout the healthcare industry. Speaking at the National Republican Congressional Committee dinner in Washington, D.C., on…
The Evolving Orphan Drug Landscape
Once considered specialized treatments for rare conditions, orphan drugs are now challenging the dominance of mainstream medications in the pharmaceutical industry. According to two recent Evaluate reports—”Are Orphans That Different?”…
The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside other therapeutics and with various complex co-morbidities.
With the growth of…
Continue Reading
Sheffield-based insomnia medtech firm SleepCogni has raised £300,000, bringing its total funding to £3.9m.
The funding was raised in an Enterprise Investment Scheme pre-approved bridging round, supported by existing investors and grants.
Richard Mills, chief executive…
Venture capital firm General Catalyst announced the expansion of the General Catalyst Institute into India, focusing on five key pillars, including using AI to address societal challenges and working with policymakers and entrepreneurs to…
Continue Reading
Big data analysis is an invaluable resource in healthcare and life sciences. Data can tell a pharmaceutical company which drugs a medical specialist prescribes and where they are based. This knowledge is key to…
Continue Reading
